ALDEYRA THERAPEUTICS, INC. Stock Issued During Period, Value, Restricted Stock Award, Gross
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ALDEYRA THERAPEUTICS, INC. stock issued during period, value, restricted stock award, gross for the quarter ending 2023-03-31 was $0.00.
- ALDEYRA THERAPEUTICS, INC. stock issued during period, value, restricted stock award, gross for the quarter ending 2020-09-30 was $57.08K.
- ALDEYRA THERAPEUTICS, INC. stock issued during period, value, restricted stock award, gross for fiscal 2017 was $7.00.
- ALDEYRA THERAPEUTICS, INC. stock issued during period, value, restricted stock award, gross for fiscal 2013 was $7.15K.
| Period end | Stock Issued During Period, Value, Restricted Stock Award, Gross 3 month | Stock Issued During Period, Value, Restricted Stock Award, Gross 12 month |
|---|---|---|
| 2023-03-31 | $0.00 10-Q · filed 2023-05-04 | |
| 2020-09-30 | $57.08K 10-Q · filed 2021-10-28 | |
| 2017-12-31 | $7.00 10-K · filed 2019-03-08 | |
| 2013-12-31 | $7.15K 10-K · filed 2015-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |